Viking Therapeutics Inc. (VKTX)
25.71
-3.16 (-10.95%)
At close: Mar 03, 2025, 3:59 PM
25.70
-0.04%
After-hours: Mar 03, 2025, 07:58 PM EST
Viking Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 26.68M | 55.52M | 36.63M | 26.37M | 29.12M | 8.38M | 24.78M | 8.99M | 3.08M | 768.55K | 755.86K | 179.62K | n/a |
| Short-Term Investments | 875.94M | 306.56M | 118.85M | 175.73M | 219.27M | 267.26M | 276.74M | 11.59M | 10.08M | 13.34M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 102K | 139K | 71K | 109K | 77K | 157K | 179K | 269.61K | 560.88K | 237.46K | 2.27M | 775.00 | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 884.02M | 5.15M | 11.55M | 8.43M | 7.72M | 405K | 278K | 1.28M | 1.65M | 2.2M | 17.83K | n/a | n/a |
| Total Current Assets | 907.22M | 367.23M | 167.04M | 210.53M | 256.1M | 283.5M | 302.13M | 21.85M | 13.97M | 15.2M | 773.68K | 179.62K | n/a |
| Property-Plant & Equipment | 1M | 1.13M | 1.42M | 25K | 321K | 598K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 1.1M | 1.26M | 1.49M | 134K | 398K | 755K | 179K | 269.61K | 560.88K | 237.46K | 2.27M | 775.00 | n/a |
| Total Assets | 908.32M | 368.49M | 168.53M | 210.66M | 256.5M | 284.26M | 302.31M | 22.12M | 14.54M | 15.44M | 3.04M | 180.39K | n/a |
| Account Payables | 9.81M | 7.51M | 8.53M | 1.44M | 3.99M | 2.43M | 959K | 1.53M | 1.2M | 592.41K | 1.83M | 74.09K | 54.03K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.28M | 1.27M | n/a | 20.32M | n/a | n/a |
| Short-Term Debt | 489K | 324K | 608K | 58K | 660K | 604K | n/a | 3.45M | 3.27M | n/a | 304.27K | 46.89K | n/a |
| Other Current Liabilities | 17.11M | 11.3M | 12.81M | 7.28M | 7.48M | 3.74M | 3.59M | 3.68M | 2M | 1.38M | 20.38M | 6.51K | 350.00 |
| Total Current Liabilities | 27.41M | 19.14M | 21.95M | 8.78M | 12.13M | 6.78M | 4.55M | 8.66M | 6.48M | 1.98M | 22.52M | 127.49K | 54.38K |
| Long-Term Debt | 630K | 936K | 1.26M | n/a | 29K | 360K | n/a | n/a | n/a | 2.15M | 1.26M | 231.85K | 42.75K |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 12K | n/a | 16.31K | 2.59M | 1.39M | 71.66K | 8.29K |
| Total Long-Term Liabilities | 630K | 936K | 1.26M | n/a | 29K | 360K | 12K | 4.98M | 16.31K | 4.74M | 2.65M | 303.51K | 51.04K |
| Total Liabilities | 28.04M | 20.07M | 23.21M | 8.78M | 12.16M | 7.14M | 4.56M | 8.66M | 6.49M | 6.71M | 25.17M | 431K | 105.42K |
| Total Debt | 1.12M | 1.26M | 1.56M | 29K | 359K | 662K | n/a | 3.45M | 3.27M | 2.15M | 1.57M | 278.75K | 42.75K |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 358.00 | 208.00 | 97.00 | 60.00 | 52.00 | 50.00 |
| Retained Earnings | -487.91M | -377.94M | -292.05M | -223.18M | -168.19M | -128.7M | -102.92M | -80.85M | -60.28M | -45.55M | -22.14M | -257.27K | -111.03K |
| Comprehensive Income | -788K | -389K | -1.1M | -549K | -54K | 12K | -423K | -19.77K | -6.89K | -7.37K | n/a | -4.5K | n/a |
| Shareholders Equity | 880.28M | 348.42M | 145.32M | 201.88M | 244.34M | 277.12M | 297.75M | 13.46M | 8.04M | 8.72M | -22.13M | -250.6K | -105.42K |
| Total Investments | 875.94M | 306.56M | 118.85M | 175.73M | 219.27M | 267.26M | 276.74M | 11.59M | 10.08M | 13.34M | n/a | n/a | n/a |